The integration of artificial intelligence (AI) within the healthcare industry is witnessing a remarkable surge, with influential companies such as Yidu Tech, YingTong Technology, Wanda Information, and ZhiYun Health being among the first to officially announce their partnership with DeepSeekThis vast consortium has resulted in over 30 healthcare organizations transitioning to integrate DeepSeek's advanced capabilitiesThese healthcare firms span multiple sectors, including drug research, imaging analysis, diagnostic screening, pathology testing, and chronic disease management, showcasing the significance of AI in transforming patient care and operational efficiency.

DeepSeek's noted attributes lie in its open-source nature and exceptional cost-effectiveness, facilitating scenarios and products previously unattainable in the healthcare domainAs one industry veteran aptly put it, while the introduction of AI heralds new possibilities, it is vital to acknowledge the hurdles regarding market validation and practical challenges like payment systems, accessibility, safety regulations, and ethical considerations that accompany these technological advancements.

One of the primary contexts where AI is finding a foothold is in the concept of "smart hospitals." A notable example is the Shenzhen People's Hospital, which recently announced its localized deployment of DeepSeekThe director of the hospital's information technology department, Ding Wanfu, explained that AI is currently employed in auxiliary diagnosticsIn collaboration with Tencent, the hospital has developed an AI-powered pre-consultation service that not only prompts patients after their registration and payment but also allows doctors to generate electronic health records based on the responses provided by the patientsThis integration signifies a progressive step towards digitized healthcare, enhancing both efficiency and accuracy in patient assessment.

Similarly, the Fourth People's Hospital of Shanghai disclosed that they have completed their own localized deployment of DeepSeek

Advertisements

Building on a repository of over 30,000 case studies and established treatment protocols, the hospital aims to provide precise decision-making support for clinicians in real-timeMoreover, on June 18, Shanghai Ruijin Hospital launched the "Ruizhi Pathology Model" in collaboration with Huawei, leveraging millisecond-level image reading capabilities to augment clinical diagnostics, thus illustrating the tactical use of AI in patient care.

In terms of diagnostic equipment, the realm of AI application diverges into a more matured domain than smart hospitals, demonstrating advancements in medical devices across myriad applicationsFor instance, Neusoft Medical's NeuBrainCARE software achieves an astonishing 95% accuracy in ischemic penumbra analyses, accomplishing this feat in under 90 seconds—a methodology that has gained traction within Chinese expert consensus guidelines.

Furthermore, years ago, United Imaging Healthcare incorporated AI algorithms into CT and PET-CT technologies, which enables lower radiation exposure during imaging diagnosis without compromising quality, thereby reflecting an ongoing commitment to patient safety and effective healthcare delivery.

Yet, the question remains whether these innovative applications will elevate operational efficiency and reduce costs within healthcare systemsZhang Yuming, the head of the China Academy of Information and Communications Technology's Medical Big Data Research Center in East China, cautioned that the efficacy of these systems should be assessed through varying lensesIn contexts such as medical record writing, aiding diagnosis, and telemedicine, the AI's ability to offer transparent reasoning might enhance doctors' proficiency in evaluation and validationContrastingly, in scenarios involving pathological analysis and imaging navigation, AI can transcend human limits, compensating for factors like distractions stemming from human emotional states, thus underscoring the necessity for accuracy and detail in medical diagnostics.

However, as the integration of AI within medical applications flourishes, it brings forth a plethora of risks and challenges

Advertisements

Wang Liansheng, the head of the Artificial Intelligence Research Institute at Xiamen University, remarked that beyond universally recognized issues of data security and privacy risks, AI models face additional hurdles in areas like inference processes, accountability, and fairnessThese elements raise substantial questions about the trustworthiness of the AI models, constraints tied to data input, and the need for regulatory frameworks to monitor these sophisticated AI entities effectively.

In addition to inherent business development risks, AI-powered medical devices—encompassing both software and hardware—encounter obstacles during pre-market registration and healthcare insurance acceptance stagesZhang elaborated that AI medical devices must undergo extensive safety and efficacy evaluations and testing before they are permitted for use in patient treatments and diagnosticsEven after market approval, there remains a continuous obligation to track adverse events and analyze outcomes.

To navigate these waters, Zhang advocated for the urgent establishment of relevant standards covering myriad aspects, including industry guidelines for AI medical devices, specification for data interfaces, algorithm evaluations, and safety certificationsTherefore, fostering interoperability and ensuring sustainable health development is crucialMoreover, ensuring the algorithms powering AI medical devices are interpretable and reliable will empower healthcare professionals and patients alike to understand the decision-making processes that underpin these technological innovations.

Regarding registration strategies for AI medical devices, Wang Jing, founder of Silicon Intelligence, proposed a meticulous classification approachCompanies ought to delineate their products accurately—those involved in diagnosing, treating, or preventing illnesses should categorically fall under the medical device classificationCompliance with pertinent regulatory requirements is essential for submitting comprehensive technical documentation and clinical data.

Furthermore, the selection of diverse and robust training and validation datasets is paramount to ensure the representativeness and diversity of the data utilized, thereby enhancing the reliability of the AI model's outcomes

Advertisements

Advertisements

Advertisements